Page last updated: 2024-10-24

caffeine and Pulmonary Disease, Chronic Obstructive

caffeine has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies

Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Kunisaki, KM1
Sin, DD1
Sweeney, D1
Hollins, F1
Gomez, E1
Saunders, R1
Challiss, RA1
Brightling, CE1
Takata, K1
Saruwatari, J1
Nakada, N1
Nakagawa, M1
Fukuda, K1
Tanaka, F1
Takenaka, S1
Mihara, S1
Marubayashi, T1
Nakagawa, K1

Other Studies

3 other studies available for caffeine and Pulmonary Disease, Chronic Obstructive

ArticleYear
Methylxanthines in COPD: yes to caffeine, no to theophylline.
    The European respiratory journal, 2021, Volume: 57, Issue:6

    Topics: Caffeine; Humans; Pulmonary Disease, Chronic Obstructive; Theophylline; Xanthines

2021
[Ca2+]i oscillations in ASM: relationship with persistent airflow obstruction in asthma.
    Respirology (Carlton, Vic.), 2014, Volume: 19, Issue:5

    Topics: Adult; Aged; Asthma; Biopsy; Caffeine; Calcium Signaling; Case-Control Studies; Female; Forced Expir

2014
Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy.
    European journal of clinical pharmacology, 2006, Volume: 62, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Asthma; Bronchodilator Agents; Caffeine; Cytochrome P-450 CYP1A2; De

2006